# Angelika Vlachou

> Angelika Vlachou is a seed investor at Brandenburg Kapital backing Biotechnology and Genetics. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Brandenburg Kapital](https://shizune.co/investors/profile/bfb-brandenburg-kapital-gmbh)
- Location: Berlin, Germany
- Total investments: 6
- Last investment: Jun 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/angelikavlachou/

Angelika Vlachou is a seed investor at Brandenburg Kapital in Berlin focused on Biotechnology and Genetics. Senior Investment Manager with Brandenburg Kapital since 2019 and management of the life science portfolio. Over ten years of experience in venture investing in the healthcare area. Actively manages investments in bio-pharma, especially drug development in neurodegenerative, chronic inflammatory, oncology, autoimmune diseases, deliverytechnologies etc. Prior strategy manager with biopharmaceutical company. She has successfully executed numerous private placements, trade sales, IPOs and licensing transactions in Europe and the U.S. Board member of Lipocalyx and board observer to Immunic Therapeutics. Angelika holds a doctorate in molecular biology from the Institut für Medizinische Virologie at the Universität of Gießen, where she graduated "summa cum laude" and a MBA degree from Potsdam University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 33% |
| Genetics | 1 | 17% |
| Oncology | 1 | 17% |
| Software | 1 | 17% |
| Biopharma | 1 | 17% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| smartbax | smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. |  | Seed | Jun 30, 2026 |  |
| smartbax | smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. | $5.5M | Seed | Oct 22, 2025 |  |
| SRTD Biotech | SRTD Biotech is an RNA-based biotechnology company that focuses on oncology, infectious, and genetic disorders. |  | Seed | Nov 14, 2024 |  |
| Mediaire | mediaire GmbH is a software for computer-based diagnosis in radiology was developed, which is locally installed | $12.7M |  | Nov 13, 2024 |  |
| smartbax | smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. | $1.3M | Seed | May 23, 2023 |  |
| faCellitate | faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research. | $3.7M | Seed | Sep 07, 2022 |  |

6 of 6 investments shown.

## Co-investors
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 3 deals together
- [Anobis Asset](https://shizune.co/investors/profile/anobis-asset) — VC Fund, 2 deals together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 2 deals together
- [UnternehmerTUM](https://shizune.co/investors/profile/unternehmertum-85e3) — VC Fund, 2 deals together
- [Arve Capital](https://shizune.co/investors/profile/arve-capital) — VC Fund, 1 deal together
- [Chemovator](https://shizune.co/investors/profile/chemovator) — VC Fund, 1 deal together

## About Brandenburg Kapital

VC Fund · Potsdam, Germany

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

5 contacts available at Brandenburg Kapital.

| Name | Title | Profile |
| --- | --- | --- |
| Angelika Vlachou | Senior Investment Manager | https://shizune.co/investors/profile/angelika-vlachou |
| Binh Vu | Venture Capital Analyst | https://shizune.co/investors/profile/binh-vu-51e3 |
| Claudia Dubro | Investment Manager | https://shizune.co/investors/profile/claudia-dubro |
| Katja Kühnel | Investment Manager | https://shizune.co/investors/profile/katja-k%C3%BChnel |
| Olav Wilms | CEO | https://shizune.co/investors/profile/olav-wilms |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Angelika Vlachou invest in?

Angelika Vlachou invests primarily in Biotechnology, Genetics and Oncology startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Angelika Vlachou last invest?

The most recent investment recorded for Angelika Vlachou closed in Jun 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co